Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Unearned Compensation
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2023   24,850,261        
Beginning balance at Dec. 31, 2023 $ 14,652,295 $ 24,850 $ 57,601,402 $ (42,879,656) $ 0 $ (94,301)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   100,000        
Exercise of stock options 71,000 $ 100 70,900      
Distributions to non-controlling interest (96,974)         (96,974)
Stock-based compensation expense 172,987   172,987      
Net (loss) income (4,673,770)     (4,760,238)   86,468
Ending balance (in shares) at Dec. 31, 2024   24,950,261        
Ending balance at Dec. 31, 2024 10,125,538 $ 24,950 57,845,289 (47,639,894) 0 (104,807)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Follow-on offering, net of transaction costs (in shares)   3,985,000        
Follow-on offering, net of transaction costs 18,105,100 $ 3,985 18,101,115      
Exercise of stock options (in shares)   575,154        
Exercise of stock options 696,779 $ 576 696,203      
Related party note conversion to common stock (in shares)   240,256        
Related party note conversion to common stock 514,148 $ 240 513,908      
Issuance of restricted stock awards (in shares)   95,808        
Issuance of restricted stock awards 0 $ 96 799,901   (799,997)  
Distributions to non-controlling interest (67,639)         (67,639)
Stock-based compensation expense 348,029   260,051   87,978  
Net (loss) income (8,249,343)     (8,248,755)   (588)
Ending balance (in shares) at Dec. 31, 2025   29,846,479        
Ending balance at Dec. 31, 2025 $ 21,472,612 $ 29,847 $ 78,216,467 $ (55,888,649) $ (712,019) $ (173,034)